{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:02:21Z","timestamp":1791216141692,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/nrneph.2010.191","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T12:21:05Z","timestamp":1296562865000},"page":"145-154","source":"Crossref","is-referenced-by-count":130,"title":["Sudden cardiac death in chronic kidney disease: epidemiology and prevention"],"prefix":"10.1038","volume":"7","author":[{"given":"M. Khaled","family":"Shamseddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"key":"BFnrneph2010191_CR1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","volume":"10","author":"PS Parfrey","year":"1999","unstructured":"Parfrey, P. S. & Foley, R. N. The clinical epidemiology of cardiac disease in chronic renal failure. J. Am. Soc. Nephrol. 10, 1606\u20131615 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2004030203","volume":"16","author":"RN Foley","year":"2005","unstructured":"Foley, R. N. et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United State Medicare population, 1998 to 1999. J. Am. Soc. Nephrol. 16, 489\u2013495 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"EL Schiffrin","year":"2007","unstructured":"Schiffrin, E. L., Lipman, M. L. & Mann, J. F. Chronic kidney disease: effects on the cardiovascular system. Circulation 116, 85\u201397 (2007).","journal-title":"Circulation"},{"issue":"Suppl. 84","key":"BFnrneph2010191_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1523-1755.63.s84.17.x","volume":"63","author":"CA Herzog","year":"2003","unstructured":"Herzog, C. A. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int. 63 (Suppl. 84), 197\u2013200 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","volume":"134","author":"JFE Mann","year":"2001","unstructured":"Mann, J. F. E. et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann. Intern. Med. 134, 629\u2013636 (2001).","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 84","key":"BFnrneph2010191_CR6","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1046\/j.1523-1755.63.s84.27.x","volume":"63","author":"JFE Mann","year":"2003","unstructured":"Mann, J. F. E., Gerstein, H. C., Dulau-Florea, I. & Lonn, E. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int. 63 (Suppl. 84), S192\u2013S196 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","volume":"12","author":"LM Ruilope","year":"2001","unstructured":"Ruilope, L. M. et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J. Am. Soc. Nephrol. 12, 218\u2013225 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR8","first-page":"1453","volume":"297","author":"AC Thomas","year":"1988","unstructured":"Thomas, A. C., Knapman, P. A., Krikler, D. M. & Davis, M. J. Community study of the causes of \u201cnatural' sudden death. BMI 297, 1453\u20131456 (1988).","journal-title":"BMI"},{"key":"BFnrneph2010191_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2215\/CJN.04571007","volume":"3","author":"E Ritz","year":"2008","unstructured":"Ritz, E. & Warnner, C. The challege of sudden death in dialysis patients. Clin. J. Am. Soc. Nephrol. 3, 920\u2013929 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh, S. K., Stack, A. G., Levin, N. W., Hulbert-Shearon, T. & Port, F. K. Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J. Am. Soc. Nephrol. 12, 2131\u20132138 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR11","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/ndt\/gfn038","volume":"23","author":"CA Herzog","year":"2008","unstructured":"Herzog, C. A., Strief, J. W., Collins, A. J. & Gilbertson, D. T. Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? Nephrol. Dial. Transplant. 23, 2629\u20132633 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2009.219","volume":"76","author":"PH Pun","year":"2009","unstructured":"Pun, P. H. et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 76, 652\u2013658 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1523-1755.2001.00806.x","volume":"60","author":"JA Karnik","year":"2001","unstructured":"Karnik, J. A. et al. Cardiac arrest and sudden death in dialysis units. Kidney Int. 60, 350\u2013357 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR14","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","volume":"69","author":"AJ Bleyer","year":"2006","unstructured":"Bleyer, A. J. et al. Characteristics of sudden death in hemodialysis patients. Kidney Int. 69, 2268\u20132273 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR15","unstructured":"US Renal Data System. USRDS 2008 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. [online] (2008)."},{"key":"BFnrneph2010191_CR16","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112\u2013S119 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR17","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1046\/j.1523-1755.1998.00154.x","volume":"54","author":"RN Foley","year":"1998","unstructured":"Foley, R. N. et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 54, 1720\u20131725 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR18","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2004121039","volume":"16","author":"PS Parfrey","year":"2005","unstructured":"Parfrey, P. S. et al. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J. Am. Soc. Nephrol. 16, 2180\u20132189 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR19","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","volume":"5","author":"RN Foley","year":"1995","unstructured":"Foley, R. N. et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J. Am. Soc. Nephrol. 5, 2024\u20132031 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2215\/CJN.07761109","volume":"5","author":"RN Foley","year":"2010","unstructured":"Foley, R. N. et al. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin. J. Am. Soc. Nephrol. 5, 805\u2013813 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1523-1755.2005.00072.x","volume":"67","author":"GA Stewart","year":"2005","unstructured":"Stewart, G. A. et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 67, 217\u2013226 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0140-6736(92)90008-Q","volume":"339","author":"S Sforzini","year":"1992","unstructured":"Sforzini, S. et al. Ventricular arrhythmias and four-year mortality in hemodialysis patients. Lancet 339, 212\u2013213 (1992).","journal-title":"Lancet"},{"key":"BFnrneph2010191_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.ajkd.2004.04.037","volume":"44","author":"Y Kitano","year":"2004","unstructured":"Kitano, Y. et al. Severe coronary stenosis is an important factor for induction and lengthy persistence of ventricular arrhythmias during and after hemodialysis. Am. J. Kidney Dis. 44, 328\u2013336 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/ki.2008.449","volume":"74","author":"RS Parekh","year":"2008","unstructured":"Parekh, R. S. et al. Severe coronary stenosis is an important factor for induction and lengthy persistence of ventricular arrhythmias during and after hemodialysis. Kidney Int. 74, 1335\u20131342 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR25","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1161\/01.CIR.0000072764.18315.6B","volume":"107","author":"MK Sinha","year":"2003","unstructured":"Sinha, M. K., Gaze, D. C., Tippins, J. R., Collinson, P. O. & Kaski, J. C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107, 2403\u20132405 (2003).","journal-title":"Circulation"},{"key":"BFnrneph2010191_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1197\/aemj.10.5.555-b","volume":"10","author":"C Pollack","year":"2003","unstructured":"Pollack, C. et al. Ischemia modified albumin is useful in risk stratification of emergency department chest pain patients. Acad. Emerg. Med. 10, 555\u2013556 (2003).","journal-title":"Acad. Emerg. Med."},{"key":"BFnrneph2010191_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/j.ajkd.2005.11.026","volume":"47","author":"R Sharma","year":"2006","unstructured":"Sharma, R. et al. Ischemia-modified albumin predicts mortality in ESRD. Am. J. Kidney Dis. 47, 493\u2013502 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacc.2007.08.057","volume":"51","author":"M Nishimura","year":"2008","unstructured":"Nishimura, M. et al. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J. Am. Coll. Cardiol. 51, 139\u2013145 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2010191_CR29","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ijcard.2007.11.070","volume":"130","author":"S Patan\u00e8","year":"2008","unstructured":"Patan\u00e8, S. et al. QT interval prolongation, torsade de pointes and renal disease. Int. J. Cardiol. 130, e71\u2013e73 (2008).","journal-title":"Int. J. Cardiol."},{"key":"BFnrneph2010191_CR30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/ndt\/13.8.1958","volume":"13","author":"K Amann","year":"1998","unstructured":"Amann, K. et al. Cardiac remodeling in experimental renal failure\u2014an immunohistochemical study. Nephrol. Dial. Transplant. 13, 1958\u20131966 (1998).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR31","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1093\/ndt\/17.12.2170","volume":"17","author":"A Covic","year":"2002","unstructured":"Covic, A. et al. Hemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease. Nephrol. Dial. Transplant. 17, 2170\u20132177 (2002).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1161\/01.CIR.97.5.467","volume":"97","author":"MC De Bruyne","year":"1998","unstructured":"De Bruyne, M. C. et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 97, 467\u2013472 (1998).","journal-title":"Circulation"},{"key":"BFnrneph2010191_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1159\/000065038","volume":"91","author":"G Kantarci","year":"2002","unstructured":"Kantarci, G., Ozener, C., Tokay, S., Bihorac, A. & Akoglu, E. QT dispersion in hemodialysis and CAPD patients. Nephron 91, 739\u2013741 (2002).","journal-title":"Nephron"},{"key":"BFnrneph2010191_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1053\/ajkd.2002.32005","volume":"39","author":"ER Beaubien","year":"2002","unstructured":"Beaubien, E. R., Pylypchuk, G. B., Akhtar, J. & Biem, H. J. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am. J. Kidney Dis. 39, 834\u2013842 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/CS20040122","volume":"107","author":"M Johnsson","year":"2004","unstructured":"Johnsson, M. et al. Elevated temporal QT variability index in patients with chronic renal failure. Clin. Sci. 107, 583\u2013588 (2004).","journal-title":"Clin. Sci."},{"key":"BFnrneph2010191_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1540-8167.1998.tb00130.x","volume":"9","author":"WL Atiga","year":"1998","unstructured":"Atiga, W. L. et al. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J. Cardiovasc. Electrophysiol. 9, 899\u2013908 (1998).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ki.1991.236","volume":"40","author":"A Agarwal","year":"1991","unstructured":"Agarwal, A., Anand, I. S., Sakhuja, V. & Chugh, K. S. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 40, 489\u2013495 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR38","volume-title":"Drug-Induced Disease: Prevention, Detection, and Management","author":"JE Tisdale","year":"2005","unstructured":"Tisdale, J. E. & Miller, D. A. Drug-Induced Disease: Prevention, Detection, and Management 2nd edn, Ch. 26 (American Society of Health-System Pharmacists, Bethesda, MD, 2005)."},{"key":"BFnrneph2010191_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/ki.2008.449","volume":"74","author":"RS Parekh","year":"2008","unstructured":"Parekh, R. S. et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int. 74, 1335\u20131342 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR40","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1681\/ASN.2005010076","volume":"16","author":"P Ravani","year":"2005","unstructured":"Ravani, P. et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449\u20132455 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrneph.2009.156","volume":"5","author":"MK Shamseddin","year":"2009","unstructured":"Shamseddin, M. K. & Parfrey, P. S. Mechanisms of the cardiorenal syndromes. Nat. Rev. Nephrol. 5, 641\u2013649 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2010191_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","volume":"61","author":"F Mallamaci","year":"2002","unstructured":"Mallamaci, F. et al. CREED Investigators: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 61, 609\u2013614 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1540-8167.1997.tb01831.x","volume":"8","author":"BF Hoffman","year":"1997","unstructured":"Hoffman, B. F., Feinmark, S. J. & Guo, S. D. Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. J. Cardiovasc. Electrophysiol. 8, 679\u2013687 (1997).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1540-8167.1996.tb00507.x","volume":"7","author":"BF Hoffman","year":"1996","unstructured":"Hoffman, B. F., Guo, S. D. & Feinmark, S. J. Arrhythmias caused by platelet activating factor. J. Cardiovasc. Electrophysiol. 7, 120\u2013133 (1996).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR45","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","volume":"108","author":"M Naghavi","year":"2003","unstructured":"Naghavi, M. et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108, 1772\u20131778 (2003).","journal-title":"Circulation"},{"key":"BFnrneph2010191_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1540-8167.2001.00369.x","volume":"12","author":"RJ Myerburg","year":"2001","unstructured":"Myerburg, R. J. Sudden cardiac death: exploring the limits of our knowledge. J. Cardiovasc. Electrophysiol. 12, 369\u2013381 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1046\/j.1523-1755.1999.00391.x","volume":"55","author":"AJ Bleyer","year":"1999","unstructured":"Bleyer, A. J., Russell, G. B. & Satko, S. G. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 55, 1553\u20131559 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR48","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ndt\/gfm730","volume":"23","author":"A Santoro","year":"2008","unstructured":"Santoro, A. et al. Patients with complex arrhythmias during and after hemodialysis suffer from different regimens of potassium removal. Nephrol. Dial. Transplant. 23, 1415\u20131421 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/pmj.78.919.273","volume":"78","author":"M Howse","year":"2002","unstructured":"Howse, M., Sastry, S. & Bell, G. M. Changes in the corrected QT interval and corrected QT dispersion during hemodialysis. Postgrad. Med. J. 78, 273\u2013275 (2002).","journal-title":"Postgrad. Med. J."},{"key":"BFnrneph2010191_CR50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. & Port, F. K. Association of serum phosphorous and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 31, 607\u2013617 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","volume":"15","author":"U Schwarz","year":"2000","unstructured":"Schwarz, U. et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol. Dial. Transplant. 15, 218\u2013233 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR52","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/15.10.1493","volume":"15","author":"K Amann","year":"2000","unstructured":"Amann, K. & Ritz, E. Microvascular disease\u2014the Cinderella of uremic heart disease. Nephrol. Dial. Transplant. 15, 1493\u20131503 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2006.03.033","volume":"191","author":"R Sharma","year":"2007","unstructured":"Sharma, R. et al. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis 191, 348\u2013354 (2007).","journal-title":"Atherosclerosis"},{"key":"BFnrneph2010191_CR54","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0018","volume":"34","author":"A Besarab","year":"1999","unstructured":"Besarab, A. Iron and cardiac disease in the end-stage renal disease setting. Am. J. Kidney Dis. 34, S18\u2013S24 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR55","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2307\/3579270","volume":"145","author":"P Wardman","year":"1996","unstructured":"Wardman, P. & Candeias, L. P. Fenton chemistry: an introduction. Radiat. Res. 145, 523\u2013531 (1996).","journal-title":"Radiat. Res."},{"key":"BFnrneph2010191_CR56","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0272-6386(04)00952-7","volume":"44","author":"VC Wu","year":"2004","unstructured":"Wu, V. C. et al. The effect of iron stores on corrected QT dispersion in patients undergoing peritoneal dialysis. Am. J. Kidney Dis. 44, 720\u2013728 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR57","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/ndt\/15.11.1735","volume":"15","author":"LC Rump","year":"2000","unstructured":"Rump, L. C., Amann, K., Orth, S. & Ritz, E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uremia? Nephrol. Dial. Transplant. 15, 1735\u20131738 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR58","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse Jr","year":"1992","unstructured":"Converse, R. L. Jr et al. Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 327, 1912\u20131918 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010191_CR59","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","volume":"11","author":"K Amann","year":"2000","unstructured":"Amann, K. et al. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J. Am. Soc. Nephrol. 11, 1469\u20131478 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR60","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI24066","volume":"115","author":"J Xu","year":"2005","unstructured":"Xu, J. et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J. Clin. Invest. 115, 1275\u20131280 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2010191_CR61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ki.1993.159","volume":"43","author":"MR Pressman","year":"1993","unstructured":"Pressman, M. R., Benz, R. L., Schleifer, C. R. & Peterson, D. D. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 43, 1134\u20131139 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR62","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.amjhyper.2005.02.002","volume":"18","author":"M Johansson","year":"2005","unstructured":"Johansson, M. et al. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure. Am. J. Hypertens. 18, 995\u20131000 (2005).","journal-title":"Am. J. Hypertens."},{"key":"BFnrneph2010191_CR63","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1152\/ajpregu.2001.280.3.R744","volume":"280","author":"M Di Rienzo","year":"2001","unstructured":"Di Rienzo, M. et al. Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, 744\u2013751 (2001).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneph2010191_CR64","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","volume":"351","author":"MT La Rovere","year":"1998","unstructured":"La Rovere, M. T., Bigger, J. T. Jr, Marcus, F. I., Mortara, A. & Schwartz, P. J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478\u2013484 (1998).","journal-title":"Lancet"},{"key":"BFnrneph2010191_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.hjh.0000254377.18983.eb","volume":"25","author":"M Johansson","year":"2007","unstructured":"Johansson, M. et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J. Hypertens. 25, 163\u2013168 (2007).","journal-title":"J. Hypertens."},{"key":"BFnrneph2010191_CR66","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","volume":"41","author":"G Cice","year":"2003","unstructured":"Cice, G. et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J. Am. Coll. Cardiol. 41, 1438\u20131444 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2010191_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2215\/CJN.02360706","volume":"2","author":"PH Pun","year":"2007","unstructured":"Pun, P. H., Lehrich, R. W., Smith, S. R. & Middleton, J. P. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin. J. Am. Soc. Nephrol. 2, 491\u2013500 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010191_CR68","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/ndt\/gfl293","volume":"21","author":"A Takahashi","year":"2006","unstructured":"Takahashi, A. et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic hemodialysis-\u2014a randomized study. Nephrol. Dial. Transplant. 21, 2507\u20132512 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861\u2013869 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010191_CR70","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","volume":"70","author":"F Zannad","year":"2006","unstructured":"Zannad, F. et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 70, 1318\u20131324 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR71","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","volume":"62","author":"RN Foley","year":"2002","unstructured":"Foley, R. N., Herzog, C. A. & Collins, A. J. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1. Kidney Int. 62, 1784\u20131790 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR72","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1523-1755.2004.00473.x","volume":"65","author":"A Ishani","year":"2004","unstructured":"Ishani, A., Herzog, C. A., Collins, A. L. & Foley, R. N. Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int. 65, 1017\u20131025 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR73","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1053\/j.ajkd.2003.08.028","volume":"42","author":"F Todd","year":"2003","unstructured":"Todd, F. et al. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 42, 1260\u20131269 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR74","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1111\/j.1523-1755.2005.00681.x","volume":"68","author":"F Van der Sman-de Beer","year":"2005","unstructured":"Van der Sman-de Beer, F. et al. NECOSAD Study Group: ACE I\/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int. 68, 2237\u20132243 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR75","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ndt\/gfh304","volume":"20","author":"MV Rocco","year":"2005","unstructured":"Rocco, M. V., Cheung, A. K., Greene, T. & Eknoyan, G. The HEMO Study: applicability and generalizability. Nephrol. Dial. Transplant. 20, 278\u2013284 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010191_CR76","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","volume":"298","author":"BF Culleton","year":"2007","unstructured":"Culleton, B. F. et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298, 1291\u20131299 (2007).","journal-title":"JAMA"},{"key":"BFnrneph2010191_CR77","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.ki.5002749","volume":"73","author":"TR Davis","year":"2008","unstructured":"Davis, T. R. et al. Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int. 73, 933\u2013939 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2010191_CR78","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1540-8159.2006.00307.x","volume":"29","author":"H Bloom","year":"2006","unstructured":"Bloom, H. et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin. Electrophysiol. 29, 142\u2013145 (2006).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrneph2010191_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1540-8167.2006.00550.x","volume":"17","author":"RE Eckart","year":"2006","unstructured":"Eckart, R. E., Gula, L. J., Reynolds, M. R., Shry, E. A. & Maisel, W. H. Mortality following defibrillator implantation in patients with renal insufficiency. J. Cardiovasc. Electrophysiol. 17, 940\u2013943 (2006).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR80","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","volume":"49","author":"A Dasgupta","year":"2007","unstructured":"Dasgupta, A. et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am. J. Kidney Dis. 49, 656\u2013663 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010191_CR81","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ahj.2005.06.042","volume":"151","author":"H Hreybe","year":"2006","unstructured":"Hreybe, H. et al. Renal insufficiency predicts the time to first appropriate defibrillator shock. Am. Heart J. 151, 852\u2013856 (2006).","journal-title":"Am. Heart J."},{"key":"BFnrneph2010191_CR82","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","volume":"30","author":"P Cuculic","year":"2007","unstructured":"Cuculic, P. et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin. Electrophysiol. 30, 207\u2013213 (2007).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrneph2010191_CR83","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1540-8167.2008.01258.x","volume":"19","author":"MS Amin","year":"2008","unstructured":"Amin, M. S. et al. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J. Cardiovasc. Electrophysiol. 19, 1275\u20131280 (2008).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneph2010191_CR84","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMsa051989","volume":"353","author":"GD Sanders","year":"2005","unstructured":"Sanders, G. D., Hlatky, M. A. & Owens, D. K. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med. 353, 1471\u20131480 (2005).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:33:59Z","timestamp":1684470839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFnrneph2010191"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.191","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}